Fingerprint
Dive into the research topics where Brian Druker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biomedical Data Manifest: A lightweight data documentation mapping to increase transparency for AI/ML
The ARTNet Consortium, Dec 1 2026, In: Scientific Data. 13, 1, 414.Research output: Contribution to journal › Article › peer-review
Open Access -
DDX41-Mutated AML: A Case Report and Perspectives
Yashar, W. M., Eide, C. A., Kurtz, S., Long, N., Johnson, K. J., Tognon, C. E., Druker, B. J., Tyner, J. W. & Swords, R., Jan 1 2026, In: JCO Precision Oncology. 10, e2500992.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Hoff, F. W., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Patel, P. A., Collins, R. H., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Redner, R. L., Kovacsovics, T., Deininger, M. W., Zeidner, J. F. & Olin, R. L. & 19 others, , Dec 1 2025, In: Blood cancer journal. 15, 1, 55.Research output: Contribution to journal › Letter › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Satpathy, S., Clark, N. M., Chen, Y. J., Hosseini, N., Chang, Y. H., Hsiao, Y., Lei, J. T., Petralia, F., Chen, J. S., Geffen, Y., Heiman, D. I., Paul, I., Cho, H., Hollenberg, M., Marino, G. B., Lin, K. T., Mannan, R., White, C. J., Allen, J. & Avanessian, S. C. & 158 others, , Sep 8 2025, In: Cancer Cell. 43, 9, p. 1731-1757.e17Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML
Zeidner, J. F., Lin, T. L., Welkie, R. L., Curran, E., Koenig, K., Stock, W., Madanat, Y. F., Swords, R., Baer, M. R., Blum, W., Stein, E. M., Olin, R. L., Schiller, G., Nichols, A., Odenike, O., Traer, E., Lachowiez, C., Duong, V. H., Hochman, M. J. & Cai, S. F. & 13 others, , Aug 10 2025, In: Journal of Clinical Oncology. 43, 23, p. 2606-2615 10 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Link opens in a new tab Scopus citations